|
US2009188630A1
|
|
Laminated Microcapsule Sheet Producing Apparatus
|
|
JP2004351033A
|
|
Method and device for producing uneven millicapsule and microcapsule
|
|
JP2003277262A
|
|
Technique of improving bioavailability of lansoprasole
|
|
JP2003252750A
|
|
Bioavailability-improving technique of water-soluble medicine with slight or low absorptivity
|
|
JP2003026605A
|
|
Improved technique for absorption promoter labrasol for hardly or low absorbable medicine
|
|
EP1284137A1
|
|
Nonoral preparation having three-layer structure
|
|
JP2002338456A
|
|
Method for producing gastrointestinal mucoadhesive patch system (gi-maps)
|
|
JP2002037745A
|
|
Technique for ameliorating bioavailability of water- soluble hardly resorptive/low resorptive drug
|
|
CN1333680A
|
|
Oral formulation for gastrointestinal drug delivery
|
|
JPH11180861A
|
|
Production of large intestinal delivery preparation capable of being collapsed by inner pressure of large intestine
|
|
JPH08253413A
|
|
Slow-releasing oral preparation of low-molecular medicine
|
|
JPH07242535A
|
|
Oral preparation for improving absorptivity of highly fat soluble scarcely water-soluble drug
|
|
JPH06256166A
|
|
Pharmaceutical preparation for controlling release of medicine
|
|
JPH0665103A
|
|
Quick-absorbable sublingual pharmaceutical for psychotropic agent
|
|
US5350741A
|
|
Enteric formulations of physiologically active peptides and proteins
|
|
JPH0477434A
|
|
Preparation of granulocyte colony stimulation factor to be applied to ocular mucous membrane
|
|
JPH0240320A
|
|
Peroral enteric pharmaceutical
|
|
JPS6438029A
|
|
Soluble and powdery preparation of cyclosporin
|
|
JPS63300774A
|
|
Embedding type liquid drug injection apparatus
|
|
JPS6272618A
|
|
Azathioprine preparation
|
